Ranking Invest

Ascendis Pharma A/S

Segmento: Healthcare Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/g for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

Indicadores Básicos

Valor de Mercado

$ 11.82 Bi

IVR

-0.16

IVR2

-0.14

Índices de Previsibilidade

Faturamento

0.62

Lucro

0.23

Margem

1.12

Índices de Tendência

Faturamento

9.47

Lucro

3.24

Margem

8.85

Índices de Endividamento

DIV/PAT

-1.74

DIV/L4T

-0.96

Dívida Líquida

$ 329.35 Mi

Patrimônio Líquido

-$ 189.81 Mi

L4T

-$ 341.67 Mi

MM4T

-147.81%

Dívidas
Dividendos
Cotação: $194.62

Não há dados de histórico de dividendos para exibir.

Gráfico Lucro/Faturamento X Trimestre